Greykasell Wealth Strategies Inc. acquired 708 shares of Regeneron Pharmaceuticals, valued at approximately $504,000. Other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback